Literature DB >> 17008976

Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in cancer patients with and without thrombosis.

Aydan Eroglu1, Arzu Ulu, Nejat Akar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17008976     DOI： 10.1007/s11239-006-9054-z

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  9 in total

1.  Factor V Leiden and PT G20210A mutations in cancer patients with and without venous thrombosis.

Authors:  A Eroglu; C Kurtman; A Ulu; R Cam; N Akar
Journal:  J Thromb Haemost       Date:  2005-06       Impact factor: 5.824

2.  Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor.

Authors:  T Ny; M Sawdey; D Lawrence; J L Millan; D J Loskutoff
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

3.  Major and potential prothrombotic genotypes in a cohort of patients with venous thromboembolism.

Authors:  M L Varela; Y P Adamczuk; R R Forastiero; M E Martinuzzo; G S Cerrato; G Pombo; L O Carreras
Journal:  Thromb Res       Date:  2001-12-01       Impact factor: 3.944

4.  The significance of hypofibrinolysis for the risk of recurrence of venous thromboembolism. Duration of Anticoagulation (DURAC) Trial Study Group.

Authors:  S Schulman; B Wiman
Journal:  Thromb Haemost       Date:  1996-04       Impact factor: 5.249

5.  Effect of plasminogen activator inhibitor-1 4G/5G polymorphism in Turkish deep vein thrombotic patients with and without FV1691 G-A.

Authors:  N Akar; E Yilmaz; E Akar; F Avcu; A Yalçin; S Cin
Journal:  Thromb Res       Date:  2000-02-15       Impact factor: 3.944

6.  Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men.

Authors:  P M Ridker; C H Hennekens; K Lindpaintner; M J Stampfer; J P Miletich
Journal:  Circulation       Date:  1997-01-07       Impact factor: 29.690

7.  The PAI-1 gene 4G/5G polymorphism and deep vein thrombosis in patients with inherited thrombophilia.

Authors:  Maria Teresa Sartori; Cristina Danesin; Graziella Saggiorato; Daniela Tormene; Paolo Simioni; Luca Spiezia; Giovanni Maurizio Patrassi; Antonio Girolami
Journal:  Clin Appl Thromb Hemost       Date:  2003-10       Impact factor: 2.389

8.  Allele 4G of gene PAI-1 associated with prothrombin mutation G20210A increases the risk for venous thrombosis.

Authors:  Doris Barcellona; Lara Fenu; Cristiana Cauli; Giulia Pisu; Francesco Marongiu
Journal:  Thromb Haemost       Date:  2003-12       Impact factor: 5.249

9.  The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells.

Authors:  S J Dawson; B Wiman; A Hamsten; F Green; S Humphries; A M Henney
Journal:  J Biol Chem       Date:  1993-05-25       Impact factor: 5.157
  9 in total
  1 in total

1.  Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab.

Authors:  F S Falvella; C Cremolini; R Miceli; F Nichetti; S Cheli; C Antoniotti; G Infante; A Martinetti; F Marmorino; E Sottotetti; R Berenato; M Caporale; A Colombo; F de Braud; M Di Bartolomeo; E Clementi; F Loupakis; F Pietrantonio
Journal:  Pharmacogenomics J       Date:  2016-03-22       Impact factor: 3.550
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.